2m 2m 2m 2m 2m 2m 2m
NEUMORA (NMRA)
NASDAQ
$1.63-$0.005 (-0.31%)
Price as of Aug 21, 2026 7:38 PM EDT- $306.3MMarket Cap
- 0.62%1-Year Change
- BiotechnologyIndustry
NEUMORA (NMRA)
$1.63-$0.005 (-0.31%)
NMRA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.63 | ||
Change | +$0.12 (+7.59%) | ||
Open | $1.51 | ||
High | $1.64 | ||
Low | $1.51 | ||
Previous Close | $1.51 | ||
Volume | 499,105 | ||
30-Day Average Volume | 725,872 | ||
1-Week Change | 1.87% | ||
1-Month Change | 0.93% | ||
1-Year Change | 0.62% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 187.9M | ||
Total Assets | $125.2M | ||
Market Cap | $306.3M | ||
Enterprise Value | $302.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$43.1M | ||
Free Cash Flow | -$39.5M | ||
EBIT | -$41.7M | ||
EBITDA | -$41.6M | ||
Net Working Capital | $97.1M | ||
EPS | -$0.23 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -7 | ||
PEG | -0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue